Today we announced an agreement with InvivoGen for the supply of our STIMULON cultured plant cell (cpc) QS-21 adjuvant. Under this collaboration, SaponiQx will manufacture cpcQS-21 for InvivoGen to sell to labs, academic institutions, and industry partners worldwide. Read more about our progress toward advancing a sustainable supply of this key adjuvant: https://lnkd.in/eiFAcsWe #QS21 #VaccineDevelopment #Adjuvants
About us
SaponiQx is a cutting edge bio-pharmaceutical company with a vision of protecting the health of populations worldwide. We seek to enable the development of safe and effective vaccines through the expansion of access to saponin based adjuvants. Contact Us! [email protected]
- Website
-
http://www.saponiQx.com
External link for SaponiQx
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Lexington, MA
- Type
- Privately Held
Locations
-
Primary
3 Forbes Road
Lexington, MA 02421, US
Employees at SaponiQx
Updates
-
We’re excited to announce that SaponiQx and Ginkgo Bioworks, Inc. have been awarded a 5-year contract totaling up to $31 million from the United States Department of Defense to leverage AI and machine learning in the discovery of novel adjuvants. The collaboration aims to equip the government with saponin-based adjuvants to enable a new wave of innovative vaccines to protect our military against existing and emerging biothreats. Learn more: https://prn.to/4bATjxt
-
SaponiQx is making important strides in vaccine adjuvant development with the availability of cGMP STIMULON from its proprietary cultured plant cell (cpc) source. STIMULON cpcQS-21 represents a sustainable alternative to traditional QS-21 produced from tree bark extract. Learn more about our advancements: https://lnkd.in/em6MNuNa #VaccineDevelopment #GlobalHealth
-
SaponiQx has achieved significant advancements across its adjuvant discovery and manufacturing. Learn more about our production of STIMULON cpcQS-21, ongoing collaborations, and regulatory progress here: https://lnkd.in/edNpUfxn
-
SaponiQx reposted this
Qs21, an adjuvant used to enhance vaccine effectiveness, is derived from Chilean tree bark and has faced supply chain issues due to limited availability of trees in Chile. SaponiQx has developed a method to produce qs21 in plant culture, eliminating the need for trees and ensuring a consistent supply. If they’re successful, they’ll make vaccines more accessible, affordable, and tailorable to combat emerging pathogens. SaponiQx is leveraging AI and molecular design to address health inequities and improve vaccine efficacy. They’re working with Ginkgo to engineer adjuvant qs21 cells, scale up production, and achieve more yield out of qs21, all while tremendously reducing costs. Interested in using Cell Engineering to get more shots on goal with your R&D dollars? Contact us to learn more about how our platform can enable you to achieve your milestones. https://hubs.la/Q01Zv8-N0 Click here to watch the full video https://hubs.la/Q01ZvflL0
-
August is #NationalImmunizationAwarenessMonth and SaponiQx remains committed to improving access to better #vaccines worldwide. Together we celebrate the power of vaccines in protecting our health and community. #Immunization is key to preventing infectious diseases and ensuring a healthier world for all.
-
SaponiQx produces QS-21 #adjuvants through a streamlined cultured plant cell manufacturing platform. Adjuvants have demonstrated their potential to reduce vaccination development & administration cost. Learn more about how pharma companies can incorporate QS-21 into a variety of vaccine candidates to enable better #vaccines. https://saponiqx.com/
-
Introducing Gui Liu, Director of Analytical Chemistry. "After the COVID-19 pandemic turned the world’s scientific spotlight on vaccine development, Gui joined the SaponiQx team because of the opportunity to apply his deep expertise in adjuvant science to a new generation of adjuvant production and discovery, and thereby advance cost-effective, superior vaccines to help safeguard the health of populations worldwide." Uncover Gui's fascinating story here. #LifeAtSaponiQx #JoinUs #Hiring
-
An #adjuvant can enhance the body’s #immune response to a vaccine, reducing the need for boosters & contributing to protecting the #patient for years after dosing. Explore how SaponiQx is leveraging cutting-edge cultured plant cell technology to expand access to #saponin adjuvants that enable better #vaccines. Visit: https://saponiqx.com/